For many Americans, booking flights and hotels are among the most stressful parts of planning a vacation. But for those with limited mobility, physical confidence issues, or medications that require special transport, their unique personal challenges can compound the typical issues associated with traveling. A recent survey reveals how weight, mobility, and health concerns are impacting travel decisions, and how GLP-1 medications like semaglutide (Ozempic) and tirzepatide (Mounjaro) are giving people the confidence and freedom to explore more destinations.
Key Takeaways
3 in 10 weight-conscious Americans have delayed or skipped a trip due to weight, mobility, or health concerns.
71% of weight-conscious Americans have looked at old travel photos and felt motivated to make a lifestyle or body change; 63% have used an upcoming trip as motivation to make a change.
Honolulu, Hawaii; Cancun, Mexico; and Miami, Florida, are the top travel destinations motivating weight loss.
41% of GLP-1 users feel more empowered to solo travel now than before treatment.
55% of GLP-1 users believe there are cities or countries that now feel more accessible because of their improved confidence or mobility.
Travel Anxiety and the Motivation To Make a Change
3 in 10 respondents have delayed or skipped a trip due to weight, mobility, or health concerns.
Gen Z was the most likely (36%).
Past and current GLP-1 users (46% and 43%, respectively) were more likely to do so than non-users (25%).
1 in 2 weight-conscious Americans have experienced heat, discomfort, and/or sweating while traveling, their top anxiety.
Women were twice as likely to experience anxiety packing or dressing for their body type than men, and 42% more likely to experience anxiety on camera or in group photos.
Top weight-related concerns when vacation planning: picking outfits (53%), taking photos (48%), and joining group activities (36%).
71% of respondents have looked at old travel photos and felt motivated to make a lifestyle or body change.
88% of current GLP-1 users experienced this.
60% of respondents have made a lifestyle change (with or without GLP-1s); 44% of them have felt an increased sense of travel freedom.
Weight-conscious Americans who have made a lifestyle change report taking nearly two times more steps now than before (on average, 3,745 before and 7,264 now).
63% of weight-conscious Americans have used an upcoming vacation or trip as motivation to lose weight.
Gen Z is the most likely to have done so (70%).
Women are more likely to have done so (68%).
Current GLP-1 users are more likely to have done so (75%).
Honolulu, Hawaii; Cancun, Mexico; and Miami, Florida, are the top travel destinations motivating weight loss.
GLP-1 Users Are Traveling More, and Further
58% of GLP-1 users have taken a trip after beginning treatment; 57% of them admit the trip felt like a reward for their progress on their medication.
55% of GLP-1 users believe there are cities or countries that now feel more accessible because of their improved confidence or mobility.
41% of GLP-1 users feel more empowered to solo travel now than before treatment.
24% of GLP-1 users have booked a trip to celebrate a weight loss milestone.
While 58% of GLP-1 users feel confident about the rules for flying with injectables, 27% aren't.
33% of GLP-1 users have skipped or delayed a GLP-1 dose while traveling to avoid hassle or embarrassment.
15% of GLP-1 users have changed a trip plan (flight, dates, schedule) to align with their injection routine.
12% of GLP-1 users have experienced issues bringing medication/needles onto a flight.
Methodology
For this study, we surveyed 1,008 weight-conscious Americans (those who consider themselves overweight) about their experiences and anxieties when traveling. Among respondents, 17% are currently taking a GLP-1; 10% have taken one previously, but no longer do.
About Levity
Levity offers personalized, medically supervised weight loss programs that help people reach their goals with the support of healthcare professionals. Whether you're exploring GLP-1 treatments like Compounded Liraglutide with B12, Wegovy, Mounjaro or Ozempic, Levity provides the tools, guidance, and ongoing care to help you travel — and live — with more freedom and confidence.
Fair Use Statement
The information in this article may be shared for noncommercial purposes only. If you reference or share it, please provide a link back to Levity with proper attribution.
.png)
.png)
